u/nadia_bakker
Contributes reviews on supplier material. Based in Nairobi.
member · joined 13 Apr 2025
Overview — page 2 of 4
comment on [Meta] proposal — a flair for co-agonism posts in c/cagrilintide · -24 points · 6 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on help me understand MASH, I have read the wiki twice in c/survodutide · 10 points · 6 months ago
Strongly agree. The safety story is separate.
comment on genuine question about Ozempic that I am slightly embarrassed to ask in c/semaglutide · 189 points · 7 months ago
the reflux passes. i promise. not medical advice.
comment on [Discussion] the MASH advice in here is 3 years out of date in c/survodutide · 3 points · 7 months ago
You have restated the marketing copy. What is the actual substance here.
comment on the semaglutide question that gets asked weekly, answered properly in c/semaglutide · 73 points · 7 months ago
Right, and the corollary is that stopping escalation does not reset your tolerance, it just pauses the clock.
comment on anyone else notice co-agonism kicking in around week 5 in c/cagrilintide · 19 points · 7 months ago
This is correct. The co-agonism is real.
comment on [PSA] receptor is not what most of this community thinks it is in c/glp1science · 93 points · 8 months ago
receptor distribution matters, GLP-1 is not everywhere
comment on the MASH question that gets asked weekly, answered properly in c/survodutide · 9 points · 8 months ago
rodent survodutide is investigation only
comment on [Results] 87 weeks, 25kg, and receptor was the hard part in c/glp1science · -41 points · 9 months ago
gastric emptying is real and explains most early fatigue
comment on the weekly dosing thing finally clicked for me and I want to write it down in c/semaglutide · 166 points · 10 months ago
my eGFR moved before the scale did and i nearly missed it
comment on [Discussion] can we stop arguing about mechanism until somebody posts a number in c/glp1science · 1 points · 10 months ago
Not convinced. The evidence does not support that reading.
comment on why does nobody talk about biopsy in c/survodutide · 47 points · 1 year ago
the MASH indication changes the risk calculus
comment on genuine question about titration that I am slightly embarrassed to ask in c/semaglutide · 626 points · 1 year ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on [Meta] proposal — a flair for pharmacy posts in c/glp1eu · 6 points · 1 year ago
apotheke, receta, EU — twenty-seven different answers
comment on prescription: what the trials say vs what this community says in c/glp1eu · 29 points · 1 year ago
Week 19 for me and the honest summary is: 23kg down, nausea manageable, and I have thought about food maybe four times today.
comment on satiety — 14 things I got wrong before I got it right in c/cagrilintide · 8 points · 1 year ago
CagriSema is a fixed combo in trials, not user-mixed
comment on satiety — 14 things I got wrong before I got it right in c/cagrilintide · 1 points · 1 year ago
Yeah, amylin is doing different work than GLP-1.
comment on satiety — 14 things I got wrong before I got it right in c/cagrilintide · 27 points · 1 year ago
comment on 7 months in and Apotheke is still the thing I get wrong in c/glp1eu · 11 points · 1 year ago
EMA notices are different from national ones
comment on REDEFINE is the most under-discussed thing in c/insurancefights in c/cagrilintide · 346 points · 1 year ago
Yeah, amylin is doing different work than GLP-1.